News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Feinstein Kean Healthcare Expands Creative Services To Meet Client Demand


10/19/2005 5:11:16 PM

CAMBRIDGE, Mass., May 10 /PRNewswire-FirstCall/ -- Feinstein Kean Healthcare (FKH), a full service communications consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that Steven Mousterakis has rejoined FKH as Vice President, Creative Services. Steven has already expanded the firm's capabilities in branding, print, interactive design and online marketing strategies.

Steven is the 9th "inside" employee (former staffers who have returned to the firm) to rejoin the FKH team in the last year, a reflection of the resurgence of the FKH consulting model. To meet demand from the growing number of clients both in FKH's Pharmaceutical Product PR practice and Biotech Corporate Communications practice, Steven has formed a Creative Studio of designers and Web developers with expertise in the development of identity systems, collateral materials, Web sites, annual reports, presentations and conference displays. FKH clients also benefit from the ability to access the extended team of award-winning designers, art directors, broadcast producers, writers and editors available at FKH's parent firm, Ogilvy PR Worldwide.

"Creative services are an integral component of a well-crafted communications plan," said Marcia A. Kean, CEO of FKH. "With Steven and his group as partners in the corporate positioning and product branding activities for clients, FKH now offers a fully integrated service that encompasses strategy, messaging and graphic identity."

Steven has close to 15 years of experience in graphic design, corporate branding, and development of identity systems for the life sciences industry, including four years of tenure at FKH from 1995 to 1999. He has worked as part of marketing teams at biotechnology companies, as well as on the agency side, and has experience working in both the pharmaceutical and biotechnology industries.

About Feinstein Kean Healthcare

Feinstein Kean Healthcare (FKH), a wholly owned subsidiary of Ogilvy Public Relations Worldwide, specializes in integrated corporate and product communications for the biotechnology and pharmaceutical industries. The firm's clients include the full spectrum of therapeutic discovery, development, and technology platform companies as well as several of the world's top 10 Big Pharma companies. For more information, visit: http://www.fkhealth.com/.

About Ogilvy Public Relations Worldwide

Ogilvy Public Relations Worldwide is a global marketing communications firm, with offices in more than 60 cities around the world. Entering its 24th year providing public relations solutions, Ogilvy Public Relations Worldwide has specialties in consumer marketing, corporate (B2B), health and medical, technology, public affairs, government relations and entertainment. Through Feinstein Kean Healthcare, Ogilvy Public Relations Worldwide provides communication consulting to pharmaceutical and biotechnology companies. Ogilvy Public Relations Worldwide is part of the WPP Group, the world's largest marketing communications company . For more information, visit our Web site at http://www.ogilvypr.com/.

Contact: Christine Mackenzie Feinstein Kean Healthcare 617-577-8110 christine.mackenzie@fkhealth.com

Ogilvy Public Relations Worldwide

CONTACT: Christine Mackenzie of Feinstein Kean Healthcare,+1-617-577-8110, or christine.mackenzie@fkhealth.com


Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES